ANTIBIOTIC-ASSOCIATED DIARRHEA: PATHOGENESIS, TREATMENT


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The paper considers different pathogenic variants of diarrhea syndrome associated with the use of antibacterial drugs. It deals with the prevention and treatment of Clostridium difficile-associated colitis in the context of evidence-based medicine. Attention focusses on the rational use of antibiotics.

全文:

受限制的访问

作者简介

N. Zakharova

I.I. Mechnikov North-Western State Medical University

Email: nvzakharova@mail.ru

参考

  1. Захарова Н.В., Жидков К.П. 2-е Рабочее совещание лидеров стационаров, включенных в проект «Стратегия и тактика использования АМП в ЛПУ России» (тезисы) / М., 22.0Л.12.
  2. Bauer M., Kuijper E., van Dissel J. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI) // Clin. Microbiol. Infect. - 2009; 1Л: 1067-79.
  3. World Gastroenterology Organisation Global Guidelines: Probiotics and prebiotics. - 2011.
  4. Stuart H. еt al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) // Infect. Control. Hosp. Epidemiol. - 2010; 31 (Л): 431-ЛЛ.
  5. Voth D., Ballard J. Clostridium difficile toxins: Mechanism of action and role in disease // Clin. Microbiol. Rev. - 200Л; 18: 247-63.
  6. Gravel D., Miller M., Simor A. et al. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: A Canadian nosocomial infection surveillance program study // Clin. Infect. Dis. - 2009; 48: Л68-76.
  7. Ricciardi R., Rothenberger D., Madoff R. et al. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States // Arch. Surg. - 2007; 142: 624-31.
  8. Redelings M., Sorvillo F., Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004 // Emerg. Infect. Dis. - 2007; 13: 1417-9.
  9. Rasko D. Clostridium difficile healthcare-associated epidemics // Nat. Genet. - 2012; 4Л (1): 6-7. doi: 10.1038/ng.2499
  10. Kuijper E. еt al. Update of Clostridium difficile infection due to PCR Ribotipe 027 in Europe // Eurosurveillance. - 2008; 13: 7-9. www.eurosurveillance.org
  11. Lessa F., Gould C., McDonald L. Current status of Clostridium difficile Infection // Clin. Infect. Dis. - 2012; ЛЛ: 6Л-70.
  12. Hu M., Katchar K., Kyne L. et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection // Gastroenterology. - 2009; 136: 1206-14.
  13. Avadhani A., Miley H. Probiotics for prevention of antibiotic-associated diarrhea and Clostridium difficile-associated disease in hospitalized adults-a metaanalysis // J. Am. Acad. Nurse. Pract. - 2011; 23 (6): 269-74.
  14. Videlock E., Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhea // Aliment. Pharmacol. Ther. - 2012; 35 (12): 1355-69.
  15. Technical guidance prepared by the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) on the update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance // EFSA J. - 2008; 732: 1-15.
  16. D'Aimmo M., Modesto M., Biavati B. Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products // Int. J. Food Microbiol. - 2007; 115 (1): 35-42.
  17. Сухорукова М.В., Тимохова А.В., Эйдельштейн М.В. и др. Чувствительность к антибиотикам штаммов бактерий, входящих в состав пробиотика «Линекс» // Клин. микробиол. и антимикроб. химиотер. - 2012; 14 (3): 248-51.
  18. Klaenhammer T. Genetics of bacteriocins produced by lactic acid bacteria // FEMS Microbiol. Rev. - 1993; 12: 39-85.
  19. Lidbeck A., Gustafsson J., Nord C. Impact of Lactobacillus acidophilus supplements on the human oropharyngeal and intestinal microflora // Scand. J. Infect. Dis. - 1987; 19 (5): 531-7.
  20. Симаненков В., Ильяшевич И., Коновалова Н. Пробиотическая терапия в комплексном лечении пневмонии // Врач. - 2010; 3: 46-9.
  21. Бондаренко В.М., Суворов А.Н. Симбиотические энтерококки и проблемы энтерококковой оппортунистической инфекции. - М., 2007.
  22. Nelson R. et al. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults // Cochrane Database Syst. Rev. - 2011; 7 (9): CD004610.
  23. Enache-Angoulvant A., Hennequin C. Invasive Saccharomyces infection: a comprehensive review // Clin. Infect. Dis. -2005; 41: 1559-68.
  24. Aas J., Gessert C., Bakken J. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube // Clin. Infect. Dis. - 2003; 36: 580-5.
  25. Babcock G., Broering T., Hernandez H. et al. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters // Infect. Immun. - 2006; 74: 6339-47.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##